The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| IRIX | -25.36% | -37.8% | -9.05% | -90% |
| S&P | +13.35% | +91.49% | +13.87% | +937% |
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $13.57M | 7.4% |
| Gross Profit | $4.60M | -8.9% |
| Gross Margin | 33.92% | -6.1% |
| Market Cap | $14.81M | -57.8% |
| Market Cap / Employee | $0.16M | 0.0% |
| Employees | 93 | -16.2% |
| Net Income | -$0.99M | 62.9% |
| EBITDA | -$0.56M | 75.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $6.78M | 64.9% |
| Accounts Receivable | $7.14M | 13.8% |
| Inventory | 8.4 | -24.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $3.92M | 203.2% |
| Short Term Debt | $1.15M | 15.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -17.34% | 14.5% |
| Return On Invested Capital | -81.81% | -38.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$0.41M | 69.1% |
| Operating Free Cash Flow | -$0.40M | 70.1% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 11.10 | 10.66 | 7.85 | 17.38 | 221.15% |
| Price to Sales | 0.61 | 0.57 | 0.34 | 0.30 | -58.03% |
| Price to Tangible Book Value | 109.04 | 104.68 | -94.11 | -11.08 | -225.17% |
| Enterprise Value to EBITDA | -19.27 | -240.30 | 117.99 | -33.93 | 130.78% |
| Return on Equity | -150.3% | -153.4% | -194.3% | -105.7% | -13.85% |
| Total Debt | $4.91M | $4.64M | $11.30M | $5.07M | 121.41% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
